PLUS THERAPEUTICS, INC. — Director's Dealing 2020

Jun 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2020-06-25

Reporting Person: Clowes Howard (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-25	Stock Option (Right to Buy)	$2.10	A	40000	Acquired	2030-06-26	Common Stock (40000)	Direct

Footnotes

F1: The options vest over two years in equal 1/24th increments on each monthly anniversary of the issuance.